Filed with ASX · · 32 pages · English
Actinogen Medical Limited has issued a letter to shareholders regarding the upcoming Annual General Meeting scheduled for the end of November. The notice includes details about the meeting's location, voting procedures, and resolutions to be discussed, such as the adoption of the remuneration report and re-elections of directors. Shareholders are encouraged to participate either in person or online, with specific instructions provided for voting by proxy. The document serves as a formal notice and includes an explanatory memorandum for shareholders to review prior to the meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
All Registry communications to: Automic Group GPO Box 5193 Sydney NSW 2001 [LOG Telephone (free call within Australia): 1300 288 664 ASX Code: ACW 28 October 2026 Upcoming Annual General Meeting of Shareholders Dear Shareholder Actinogen Medical Limited ACN 086 778 476 (ASX: ACW or “the...
Actinogen Medical Limited on 6ix
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical